论文部分内容阅读
目的:评价磷酸奥司他韦对流行性感冒(简称“流感”)患儿的临床疗效。方法:选取2014年3月—2015年3月收治的流行性感冒患儿44例,将其随机分为对照组和观察组,每组22例;对照组患者仅给予普通抗感冒药物治疗,观察组患儿均给予磷酸奥司他韦颗粒治疗,观察两组患儿治疗后的总有效率和不良反应的发生情况。结果:观察组患儿治疗后总有效率为86.36%,显著高于对照组为72.73%(P<0.05);观察组患者治疗后不良反应的发生率为9.09%,显著低于对照组为22.73%(P<0.05);观察组患儿治疗后流感持续时间、退热时间、症状缓解时间显著短于对照组(P<0.05)。结论:磷酸奥司他韦颗粒对流感患者临床疗效较好,能快速缓解患儿症状,且安全有效,不良反应的发生率较低。
Objective: To evaluate the clinical efficacy of oseltamivir phosphate in children with influenza (“flu”). Methods: Forty-four children with influenza were selected from March 2014 to March 2015. They were randomly divided into control group and observation group, with 22 cases in each group. Patients in the control group were treated with common anti-cold drugs only, and observed All patients in the group were given oseltamivir phosphate granules. The total effective rate and adverse reactions of the two groups were observed. Results: The total effective rate of the observation group was 86.36%, significantly higher than that of the control group (72.73%, P <0.05). The incidence of adverse reactions in the observation group was 9.09%, significantly lower than that of the control group % (P <0.05). The duration of flu, antipyretic time and symptom relieving time in the observation group were significantly shorter than those in the control group after treatment (P <0.05). CONCLUSION: The oseltamivir phosphate granule has a good clinical effect on patients with influenza and can quickly relieve the symptoms in children, and is safe and effective with a low incidence of adverse reactions.